Loading clinical trials...

Long-term Treatment on BAY77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in Bone | Clinical Trials | Clareo Health

COMPLETEDPHASE2

Long-term Treatment on BAY77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in Bone

Open Label, Non-controlled Long-term Treatment on BAY77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in Bone in Patients With Hyperphosphatemia Receiving Dialysis

NCT00767637•Bayer

View on ClinicalTrials.gov

Summary

To measure lanthanum concentrations in bone in patients with hyperphosphatemia receiving dialysis

Eligibility

Age

20 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patients undergoing dialysis or plan to start dialysis before the initial administration of the study medication

Exclusion Criteria

•Patients with severe hypocalcemia (adjusted serum calcium level of \<7.5 mg/dL)

Locations (2)

Isesaki, Gunma, Japan

Yonago, Tottori, Japan

Key Dates

Start Date

June 1, 2005

Primary Completion Date

October 1, 2008

Completion Date

October 1, 2008

Last Updated

June 20, 2014

Enrollment

ACTUAL participants

Conditions

HyperphosphatemiaDialysis

Interventions

Lanthanum Carbonate (BAY77-1931)

DRUG

Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study

NCT06884280

Peritoneal DialysisAnaemia+1 more

View study

RECRUITINGNA

The Effectiveness of Education in Diabetic Hemodialysis Patients

NCT07462741

Hemodialysis PatientDiabetes Foot Care

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 20, 2014Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Long-term Treatment on BAY77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in Bone

Inclusion Criteria

Exclusion Criteria

Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study

The Effectiveness of Education in Diabetic Hemodialysis Patients

WISDOM UK: Low Dose-intensity Versus Standard Dose-intensity CRRT in Critically Ill Patients

Outpatient Recovery From Acute Kidney Injury Requiring Dialysis - 2

A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China

Blood Pressure Control With Thiazide Diuretics in Peritoneal Dialysis Patients